Week beginning 4th December 2023
News, advocacy and media
Trial by Error by David Tuller Dutch Survey respondents Rate GET/CBT as "the Worst" Approach, Per New Report
Graded exercise therapy was rated as the worst intervention in a Dutch survey with more than 1500 ME/CFS participants. The survey is part of the development of new treatment guidelines and Tuller writes about the expected backlash from professionals with vested interests in such approaches.
Article l
Thread
USA CDC National Center for Health Statistics
A National Health Interview survey conducted in 2021-2022 found that 1.3% of adults in the USA had ME/CFS. Women (1.7%) were more likely than men (0.9%) to have ME/CFS. Adults in families with lower income also had higher rates of ME/CFS.
Report |
Thread
UK ME Association AGM 11th December. The Chairman's report includes changes to staff and trustees, and aspects of their work helping people with ME through ME Connect, advocacy particularly related to implemention of the NICE guideline, and funding research.
Article |
Thread
Sweden The public broadcaster SVT has done three articles about undocumented ME treatment at the private Amelie clinic. The treatments include the antiviral drug Valganciclovir and the HIV drug Ritonavir. Some patients have reported the clinic which has led to a lot of debate within the patient community. The immunologist Jonas Axelsson is the clinic's doctor and says his approach is evidence based practice. Dr. Axelsson had initiated a clinical trial on Valganciclovir, but the project has been stopped.
Articles
1 2 3 4 l
Thread
Sweden Journalist Agnis Arpi has written a text for the feminist magazine Hertha about lack of resources directed towards women's health and mentions ME as one example.
Article l
Thread
Aotearoa New Zealand RNZ Saturday
Sean O'Neill discusses his daughter Maeve, who died at the age of 27 in 2021 from malnutrition in the context of very severe ME/CFS. An official inquest into her care under the UK NHS is in process. Further comments by Otago's Emeritus Prof Warren Tate.
Link |
Thread
Germany The newspaper Frankfurter Allgemeine with article about ME sufferer Jonas.
Article l
Thread
..........
Coming events
Bateman Horne Center - Lunch and Learn
Topic: My Favorite Things
Thursday, December 14, 11:30 AM - 1:30 PM Mountain Time
(see thread for time in your time zone)
Announcement |
Thread
#MEAction - Partner Caregiver Support Call
Sunday, December 16
3:00 - 4:00 PM Eastern time
Zoom call for partner caregivers of people with ME or Long COVID.
(see thread for time in your time zone)
Announcement |
Thread
Finland Webinar 24.01.2024 on Long Covid, ME/CFS and hyper mobility. Organised by Suomen Psykofyysisen Fysioterapian Yhdistys.
More information l
Thread
.........
Research news
UK DecodeME Coming soon – DecodeME’s Second Questionnaire
Everyone who submitted the first questionnaire will be invited to complete a second questionnaire. "This second questionnaire is designed to complement the first by delving deeper into your experience of ME/CFS."
Article |
Thread
"If you have been invited to the DNA stage, and have yet to return your spit kit, please do so by the 31 January 2024. The more samples we have the better the science will be!"
Website |
Thread
Workwell Foundation Workwell Teams up with STAT Health
Blog post about an in-ear wearable device that tracks blood flow to the head. "Workwell and STAT Health hope to understand whether blood flow to the head is reduced during PEM and if this index helps explain the worsened orthostatic symptoms that many report."
Blog |
Thread
NL Times Netherlands to lead major study to test existing medications for long Covid treatment
"Preparations are underway in the Netherlands for an extensive European study aimed at determining whether existing, readily available, and affordable medications can alleviate symptoms in long Covid patients, NOS reported on Friday."
Article |
Thread
Academic Medical Education
The recording of the 'Demystifying Long COVID International Conference 2023' has been put online on Youtube.
Day 1 |
Day 2 |
Day 3 |
Thread
...........
Research
ME/CFS research
International Journal of Molecular Sciences
Investigating the Human Intestinal DNA Virome and Predicting Disease-Associated Virus–Host Interactions in Severe ME/CFS - Hsieh, Carding et al.
"Using an in silico approach, we predicted interactions between members of the Anaerotruncus genus and unique viruses present in ME/CFS microbiomes."
Article |
Thread
Preprint
Immunological Patient Stratification in ME/CFS - Rohrhofer et al
An attempt to stratify people with ME/CFS into two groups based on their immune competence and to relate this to "inflammatory immune mediators and biomarkers for intestinal barrier integrity".
Preprint |
Thread
Frontiers in Physiology
Post-exertional malaise in daily life and experimental exercise models in patients with [ME/CFS] - Vollestad & Mengshoel
This review argues that "there are indications of altered muscular metabolism and autonomic nervous responses if exercise is repeated on successive days in patients with ME/CFS."
Article |
Thread
MMW - Fortschritte der Medizin
Implications of the quality of the doctor-patient relationship on health in adult ME/CFS patients. A qualitative public health study from a patient perspective - Horstmeier & Horstmeier
This article in German summarises the findings of a survey on 544 ME/CFS patients. Participants reported a significant deterioration in their health as a result of misdiagnoses, incorrect treatments, and the lack of support from the physicians.
Article |
Thread
Long Covid research
Preprint: BioRxiv
Dysregulated Platelet Function in Patients with Post-Acute Sequelae of COVID-19 — Anu Aggarwal et al.
“The most significant finding in our study is that platelet-deplete plasma in PASC patients ‘primes’ and markedly activates healthy, washed platelets through every receptor signaling pathway evaluated.” ”The hyper-reactive platelet effect caused by PASC plasma persisted even after heating plasma to 55°C suggesting the complement cascade or circulating antibodies are likely not responsible for augmented platelet activation.”
Article |
Thread
Clinical Nutrition ESPEN
Maximal oxidative capacity during exercise is associated with muscle power output in patients with long coronavirus disease 2019 (COVID-19) syndrome. A moderation analysis — Robinson Ramírez-Vélez et al.
“In summary, we have provided a preliminary report of lower [maximal fatty acid oxidation] during exercise in patients with LCS compared with healthy controls, potentially indicating mitochondrial dysfunction.”
Article |
Thread
Journal of Proteome Research
Proteomic Evolution from Acute to Post-COVID-19 Conditions — Yassene Mohammed et al.
“Proteins associated with six key lipid-related pathways increased from admission to 3 and 6 months; conversely, proteins related to innate immune responses and vasoconstriction-related proteins decreased.”
Article |
Thread
Preprint: MedRxiv
Long COVID is associated with severe cognitive slowing — Sijia Zhao et al.
“We identified pronounced cognitive slowing in PCC patients, which distinguished them from age-matched healthy individuals who previously had symptomatic COVID-19 but did not manifest PCC.”
Article |
Thread
International Journal of Epidemiology
Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia — Gwaikolo et al.
“Our findings suggest that the long-term health impact of COVID-19 in people infected during this period of the pandemic in [sub-Saharan Africa] could be more significant than previously recognized.”
Article |
Thread
Nature Scientific Reports
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis — Frallonardo et al.
“In this study, fatigue was the most common symptom (35.4%, 95%CI 25.6–45.2) which represents the most debilitating long COVID symptom, and the first reason patients seek for medical assistance. This is concerning because, in Africa, it has the potential to lead to important impairment in productivity and further loss of economic agency.”
Article |
Thread
Nature Reviews Neuroscience
The neurobiology of SARS-CoV-2 infection — Meinhardt et al.
“In this Review, we put special emphasis on discussing the methodological difficulties of viral detection in CNS tissue and discuss immune-based (systemic and central) effects contributing to COVID-19-related CNS affection.”
Article |
Thread
The Lancet Infectious Diseases
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial — Raphaela I Lau et al.
“We identified favourable changes in the gut microbiome, including increased bacterial diversity and short-chain acid-producing bacteria and decreased resistome in the SIM01 group but not placebo group after 6 months of treatment” “The present study did not identify a significant difference in quality of life and physical activity between the two groups at 6 months.”
Article |
Thread
............
S4ME social media:
Forum,
Facebook,
Twitter,
Mastodon and
YouTube